Results 121 to 130 of about 3,930 (204)

Establishment and validation of a nomogram containing cytokeratin fragment antigen 21-1 for the differential diagnosis of intrahepatic cholangiocarcinoma and hepatocellular carcinoma

open access: yesFrontiers in Oncology
BackgroundOur study aimed to develop a nomogram incorporating cytokeratin fragment antigen 21–1 (CYFRA21–1) to assist in differentiating between patients with intrahepatic cholangiocarcinoma (ICC) and hepatocellular carcinoma (HCC).MethodsA total of 487 ...
Yuan-Yuan Liu   +4 more
doaj   +1 more source

Comparison Study of Cyfra 21-1, Carcinoembryonic Antigen and Telomerase Activity between Non Small Cell and Small Cell Lung Cancer Patients

open access: yesپزشکی بالینی ابن سینا, 2008
Introduction & Objective: The roles of tumor markers in the prognosis and diagnosis of lung cancer is under investigation. The aim of this study was to examine correlation between serum levels of Carcinoembryonic Antigen (CEA) and Cyfra 21-1 with ...
Behrang Alani   +3 more
doaj  

CEA、Cyfra21-1、NSE、Ca50联合检测在肺癌中诊断价值

open access: yesZhongguo shiyan zhenduanxue, 2007
目的探讨肿瘤标志物CEA、Cyfra21-1、NSE、Ca50联合检测在肺癌中诊断价值。方法应用电化学发光免疫分析及免疫放射分析法对214例肺癌、28例良性病变、32例健康人测定血清肿瘤标志物水平。结果214例肺癌血清肿瘤标志物CEA、Cyfra21-1、NSE、Ca50水平高于良性病变、健康组 ...
陈武, 刘洋, 范艳红, 贺贵福
doaj  

A surgical case of pulmonary actinomycosis with elevated serum CYFRA21-1 levels

open access: yesThe Journal of the Japanese Association for Chest Surgery, 2020
Hiroki Watanabe   +2 more
openaire   +2 more sources

端粒酶和CYFRA 21-1测定对良恶性胸腔积液的诊断价值

open access: yesZhongguo shiyan zhenduanxue, 2006
目的研究胸腔积液端粒酶活性及CYFRA21-1在良、恶性胸腔积液中的诊断价值。方法用聚合酶链反应—酶联免疫吸附分析法(PCR-ELISA)检测胸腔积液端粒酶活性,用免疫放射分析法(IRA)测定胸液CYFRA21-1水平,并与细胞学诊断结果进行比较,根据最终的诊断结果,67例患者分成2组:(1)非恶性胸腔积液35例;(2)恶性胸腔积液32例。结果非恶性胸腔积液中端粒酶阳性2例(5.7%),恶性胸腔积液阳性26例(81.3%),端粒酶活性测定诊断恶性胸腔积液的灵敏度为81.3%,特异度94%,正确率93 ...
魏仲航, 杨杰, 魏延君
doaj  

Home - About - Disclaimer - Privacy